Canbi  Pharma  Teknoloġiku  Limited
1691249-45-2 Zanubrutinib
1691249-45-2 Zanubrutinib

1691249-45-2 Zanubrutinib

CAS: 1691249-45-2
MF: C27H29N5O3
MW: 471.55
Einecs:
MDL No.:MFCD31567461

Ibgħat l-inkjesta
Deskrizzjoni

Proprjetajiet

Dehra bajda għal solidu abjad
Punt tat-togħlija: 713.4 ± 6 0. 0 grad
Densità 1.33 ± 0. 1 g / cm3
 

Applikazzjoni:

Zanubrutinib, bħala inibitur tal-BTK żviluppat ġdid u potenti, għadda minn ottimizzazzjoni tal-istruttura molekulari biex tinkiseb inibizzjoni preċiża kompluta u sostnuta tal-miri BTK.
Zebutinib huwa inibitur qawwi tal-BTK li ġie ttestjat klinikament bħala monoterapija jew flimkien ma 'terapiji oħra għat-trattament ta' diversi limfomi

 

Sinonimi:

Zanubrutinib

1691249-45-2

Brukinsa

(7s) -2- (4- phenoxyphenyl) -7- ({1- prop {-2- enoylPiperidin -4- yl) -4, 5,6, 7- tetrahydropyrazolo [1, {5- a] pirimidina -3- carboxamide

(7s) -2- (4- phenoxyphenyl) -7- [{1- (prop {-2- enoyl) piperidin {{ 6}} yl] -4 h, 5H, 6H, 7H-Pyrazolo [1, 5- a] pyrimidine -3- carboxamide

1691249-45-2 (s-isomer)

(S) -7- (1- acryloylpiperidin -4- yl) {-2- ({4- phenoxyphenyl) {{{5 }}, 5,6, 7- tetrahydropyrazolo [1, 5- a] pyrimidine -3- carboxamide

Kompost 27b

(7s) -2- (4- phenoxyphenyl) -7- ({1- (prop {-2- enoyl) piperidin -4- yl ) -4, 5,6, 7- tetrahydropyrazolo (1, {5- a) pirimidina -3- carboxamide

(7s) -4, 5,6, 7- tetrahydro -7- [{{{{1- ({1- oxo -2-} propen {-1- yl) -4- piper iDinyl] -2- (4- phenoxyphenyl) Pyrazolo [1, 5- a] pirimidina -3- carboxamide

Pyrazolo (1, 5- a) pirimidina -3- carboxamide, 4,5,6, 7- tetrahydro -7- (1- ({1- oxo -2- propen { {11}} yl) -4- piperidinyl) -2- (4- phenoxyphenyl) -,,,, (7s) -

Zanubrutinibum

 

 

 

It-tags Popolari: 1691249-45-2 Zanubrutinib, iċ-Ċina 1691249-45-2 Manifatturi Zanubrutinib, fornituri

Inquiry
goTop

(0/10)

clearall